Last Updated on June 22, 2025 by The Health Master
Drugs Rules
Download the draft notification on Drugs Rules 1945: Recently, the Union Health Ministry issued a draft notification vide No. GSR 345(E) dt 28-05-2025 for amendments to the Drugs Rules, 1945.
Based on the recommendations of the Drugs Consultative Committee (DCC) and the Drugs Technical Advisory Board (DTAB), these amendments are likely to increase the safety of public health, decrease testing necessities, and erase regulatory ambiguity.
Bacterial Endotoxin Testing
For example, one of the amendments relating to safety enhancements will apply to parenteral drugs.
The draft notification seeks to insert a substitution of Rule 121A of the Drugs Rules.
Currently, under the Drugs Rules, a pyrogen test is needed for certain large-volume parenterals (more than 10 ml).
The proposed substitution will insert, however, that “the test for bacterial endotoxins-pyrogens shall be carried out as per the current edition of the Indian Pharmacopoeia (IP).”
Wholesale: Competent Person requirement
There are more requirements for wholesale drug licensing.
Proposed amendments to Forms 20B and 20G (applications for wholesale drug licenses under Schedules G and H, respectively) provide for more competent person qualifications for wholesale licenses.
Key changes include:
Sale Under Personal Supervision:
A new condition will be added that states that all sales must be made under the personal supervision of a competent person, whose name shall be mentioned in the license.
Reasonable Timeframe for Condition Changes:
The condition of the license will be amended to require that, if any change occurs in the competent person, the same shall be informed to the licensing authority within one month of such change.
Sales Restrictions to Non-Pharmaceutical Manufacturers
Wholesalers having Form 20B and 20BB did not require a license when selling drugs to non-drug manufacturers, even when those drugs were being used in their operations.
This amendment corrects this lapse.
The proposed amendments shall:
Delete Non-Pharmaceutical Exemption:
The general clause allowing wholesalers of scheduled drugs to sell to non-drug manufacturers without requiring a license shall be removed.
Required Condition Limitations:
A new proviso shall be added that states, “Provided further that the conditions shall also not apply to the sale of any drug except antimicrobial drugs to a manufacturer of beverages, confectionery, biscuits, and other non-medicinal products, where such drugs are required for processing these products.”
Similar changes will happen to Forms 21-B and 21BB regarding sales to manufacturers of hydrogenated vegetable oils, beverages, confectionery, and other non-medicinal products.
Schedule H & K
The draft notification seeks to amend by exempting some chemical contraceptives from provisions of Schedule H, located in Serial No. 15.
This shall be done by inserting the fifth footnote to Schedule H: “Class of drugs mentioned at serial no. 15 of Schedule K shall not be covered under this Schedule.”
Public Feedback
The public has 30 days from publication in the Official Gazette to respond.
“Objections and suggestions that may be received from any person within the period specified above will be considered by the central government,” read the ministry.
Q. What are the main changes in the Drug Rules 1945 ?
The changes are not concentrated in just one area but are strategically spread across Rules (specifically Rule 121A), various Forms (20B, 20G, 20BB, 21B, 21BB), and Schedules (H and K) to address different facets of drug regulation in India.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
DTAB recommends key amendments of MDR, 2017
DCC recommends amendment of Rules to curb Antimicrobial Resistance
Veterinary Drug Bust: ₹3 Lakh Illicit Stock Seized
CDSCO: New Labeling Guidelines for Imported drugs
CDSCO Guidelines: Safe Disposal of Expired and Unused Drugs
India to Ban 34 Antimicrobials for animal use
USFDA approval granted for Amlodipine & Atorvastatin Tablets USP
USFDA issues warning on Allergy medicines
FSSAI: Food Labelling and Display – Chapter-18
42 Companies banned over supply of NSQ drugs: Rajasthan
83,090 Tablets of Alprazolam and Zolpidem Seized, 1 Arrested
